The Global Blood Screening Market is expected to register a growth of significant CAGR 9.8% during the forecast period (2018–2023). Blood screening is a medical process in which the blood is examined for the diagnosis of a specific diseased condition is known as blood screening. Exhaustive screening is essential for all donated blood to confirm that recipients receive the safest products. Scientific advances increase the sensitivity and effectiveness of the tests. For example, in August 2016, the Food and Drug Administration (FDA) suggested the testing of all the donated blood in the U.S. and its territories for Zika virus in order to prevent transmission of this virus through the blood supply.
The technology is cheaper and faster than earlier DNA analysis methods. The growth of the market is credited to the rise in demand for blood screening tests due to growing blood donations, increasing awareness about transfusion-transmitted diseases, and technological developments in the industry. Additionally, governments of various countries are in process to mandates testing all donated blood for several viruses.
Request Free Sample Report @ https://www.marketresearchfuture.com/sample_request/6899
Blood Screening Market Segmentation:
The global blood screening market has been segmented on the
- devices
- service providers
- application
- end users
On the basis of technology, the market has been classified as
- rapid tests,
- next-generation sequencing (NGS),
- western blotting.
- nucleic acid amplification test (NAT),
- enzyme-linked immunosorbent assay (ELISA),
The nucleic acid amplification test is segmented in to
- transcription-mediated amplification (TMA)
- real-time polymerase chain reaction (PCR).
The enzyme-linked immunosorbent assay is segmented in to
- ELISA market by platform
- ELISA market by generation.
On the basis of products and services, the market has been classified as
reagent and kits,
- enzymes and polymerases
- standards and controls
- probes and primers
- buffers
- nucleotides
- solutions
- immunosorbents
- instruments, software and services
The reagent and kits have been segmented in to NAT reagents & kits, ELISA reagents & kits. The instruments have been segmented in to rental purchase and outright purchase. On the basis of end users, the market has been classified as hospitals, clinics, research institutes and academic centers, blood banks and others.
Blood Screening Market Regional Analysis:
America
The Americas is projected to lead the blood screening market in the forecast period. Increasing healthcare awareness, advancement in technology, medical tourism are some other factors that boost the growth of the market. U.S. blood screening market dominated industry in 2017, due to the high demand for quality healthcare, vastly developed healthcare infrastructure as well as growing occurrence of cardiac disease in the region. Frequencies of blood screening are dramatically increasing over the last few years. Lately, the Food and Drug Administration (FDA) published a guidance document suggesting regulations for laboratory developed tests. In addition, In February 2015, the U.S. FDA conducted a workshop to discuss the oversight of NGS. All these factors increase awareness, which would further increase the growth of the industry.
European
The European market is expected to hold the second largest market share. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow.
Asia-Pacific
Asia-Pacific is projected to be the fastest growing region for the global blood screening market in 2018. It is expected to witness profitable growth over the forecast period due to the existence of favorable healthcare schemes drafted by government agencies Other factors such as growing elderly population, rising demand for advanced and high-end technologies, healthcare reforms for infrastructural development and growing healthcare expenditure are some of the key factors that will accelerate the blood screening market growth during the forecast period.
The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.
Browse Full Research Report @ https://www.marketresearchfuture.com/reports/blood-screening-market-6899
Blood Screening Market Key Players:
Some of the key players in the global blood screening market are
- Grifols,
- F. Hoffmann-La Roche,
- Abbott Laboratories,
- Biomérieux,
- Bio-Rad Laboratories, Inc.,
- Siemens Healthineers
- Ortho Clinical Diagnostics, Inc.,
- Thermo Fisher Scientific, Inc.,
- Beckman Coulter
- Becton,
- Dickinson
Brows More Healthcare Related Research Reports:
Pediatric Medical Device Market Dynamics | Trends and Insights | Forecast To 2023
Infection Control Market Profile | Growth and SWOT Analysis Forecast To 2023
For More Details Please Visit @ Market Research Future
Global Blood Screening Market Forecast to 2027 encompasses crucial data about the global Blood Screening market and includes a thorough examination of technological development, market drivers, market share, market size, and regional segmentation.
The report also provides a comprehensive evaluation of the market trends, vital statistical data, accurate market estimations, and the key suppliers and manufacturers of the Blood Screening market.The report is also attuned with the currently ongoing COVID-19 pandemic and its effect on the key segments of the market.
The pandemic resulted in an economic slowdown and has directly affected the business sector by impacting the supply chains and availability of raw materials.
The report is updated with the impact of COVID-19 crisis, economic landscape, and present and future impact of COVID-19 on the market.
The report also aims to benefit the user by providing constructive data to gain insight into the market growth, size, and investment approaches.The key companies profiled in the market are: Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Ortho-Clinical Diagnostics, Inc., Grifols, Siemens Healthcare GmbH, SOFINA S.A, and Thermo Fisher Scientific.The report also covers a comprehensive analysis of the strategic alliances such as mergers and acquisitions, joint ventures, partnerships, collaborations, agreements, government and corporate deals, and product launches and brand promotions.
The report also offers a thorough analysis of the product portfolios, production capacity, gross margins, revenues, and costing of the key manufacturers and vendors.
Blood Screening Market: By Technology (Nucleic Acid Amplification Test, Enzyme-Linked Immunosorbent Assay, Next-Generation Sequencing), By Product and Services (Reagents, Instruments) and End User (Hospitals and Clinics) — Global Forecast till 2023Market Highlights:The Global Blood Screening Market is expected to register a growth of significant CAGR 9.8% during the forecast period (2018–2023).Blood screening is a medical process in which the blood is examined for the diagnosis of a specific diseased condition is known as blood screening.
Additionally, governments of various countries are in process to mandates testing all donated blood for several viruses.Avail a Free Sample@ https://www.medgadget.com/2020/09/blood-screening-market-2020-industry-covid-19-impact-forecast-by-size-share-estimation-growth-impact-healthcare-sector-insights-and-global-trends-analysis-to-2026.html Segmentation:The global blood screening market has been segmented on the devices, service providers, application, end users.On the basis of technology, the market has been classified as nucleic acid amplification test (NAT), enzyme-linked immunosorbent assay (ELISA), rapid tests, next-generation sequencing (NGS), western blotting.
The nucleic acid amplification test is segmented in to transcription-mediated amplification (TMA) and real-time polymerase chain reaction (PCR).
The enzyme-linked immunosorbent assay is segmented in to ELISA market, by platform and ELISA market, by generation.
On the basis of end users, the market has been classified as hospitals, clinics, research institutes and academic centers, blood banks and others.Regional Analysis:The Americas is projected to lead the blood screening market in the forecast period.
Frequencies of blood screening are dramatically increasing over the last few years.
Market ScenarioThe Global Blood Glucose Monitoring Market is predicted to register 10.7% CAGR during the forecast period (2017-2023) owing to the increased diabetic population across the globe, asserts Market Research Future (MRFR).
Blood Glucose Monitoring is referred to as the process of testing diabetes level in the blood which helps to identify the glucose level in the blood within a specific target range.Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4921The various blood glucose monitoring devices available in the market are termed as blood glucose meter.
These devices offer useful insights to manage diabetes and helps in tracking the progress of treatment goal.
Moreover, physical inactiveness and unhealthy diet has further contributed to the market growth.Increasing awareness of diabetes, development of new technologies, and rising investment in research and development activities have fueled the market growth during the appraisal period.
Huge surge in the geriatric population and rising product launch and approvals are further influencing the market growth.On the flip side, high cost associated with the monitoring and diagnosis of diseases is one of the major concerns considered to impede the market growth in the coming years.Moreover, product recalls coupled with inadequate reimbursements are some of the factors presumed to dampen the market growth to an extent.Global Blood Glucose Monitoring Market: Segmental AnalysisThe Global Blood Glucose Monitoring Market has been segmented on the basis of application, product type, end-user, and region.By mode of product type, the global blood glucose monitoring market has been segmented into continuous glucose monitoring devices (CGM), invasive glucose monitoring devices, flash glucose monitoring devices, and others.By mode of application, the global blood glucose monitoring market has been segmented intotype 1 diabetes, type 2 diabetes, and others.Type-I and type-II diabetes are further sub-segmented into pediatrics and adult.
The rising prevalence of type-II diabetes is fueling the growth of the use of blood glucose monitoring system.By mode of end-users, the global blood glucose monitoring market has been segmented intohospitals, diagnostic centers, research centers, clinics,and home care diagnostics.
Global Diabetes Monitors Market Research Report By Sample (Blood, Sweat, Urine), Type (Point Sample Test-Based Glucose Monitors, CGM, Component (Lancet, Glucose Test Strips, Sensors (Enzyme Based and Enzyme Free Sensors)), End Users - Forecast till 2023Market HighlightsDiabetes is a metabolic disease that occurs when blood glucose level is too high either due to inadequate insulin production or because of low response towards insulin.
The three most common type of diabetes are Type 1, Type 2, and gestational diabetes.
Other less common type includes cystic fibrosis-related diabetes, and monogenic diabetes.
It is also estimated that around 1.6 million deaths have occurred in 2015 due to diabetes worldwide.Rise in technological innovations, huge research funding for diabetes diagnosis and treatment, increasing prevalence and incidence of diabetes, rising approval from regulatory bodies, and increasing global obesity population.
However, high cost associated with diagnosis and treatment of diabetes, and stringent reimbursement policies may hinder the growth of market to an extent.It is estimated that diabetes monitors market is expected to grow at a CAGR 8.3% during the forecast period 2017-2023.Taste the market data and market information presented through more than 296 market data tables and figures spread over 251 pages of the project report.
Avail the in-depth table of content TOC & market synopsis on “diabetes monitors market research report–Global forecast till 2023.”Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/4781Major Key Players in Global Diabetes Monitors MarketSome of key the players in the market are Panasonic, Abbott Laboratories, Dexcom, Inc., F. Hoffmann-La Roche Ltd , Medtronic, LifeScan, Inc., Sanofi, and others.The global diabetes monitors market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.The Americas is the leading market across the globe on account of increasing patient population.
Spongiform Encephalopathy Market Information: By Type (Creutzfeldt Jakob, Vcjd, BSE, Scrapie, CWD), Diagnosis (Histopathology, Immunochemical Detection, Animal Bioassay, others), Treatment (Small Molecule, Immunotherapy), End User - Global Forecast till 2027Market HighlightsTransmissible spongiform encephalopathy (TSEs) or prion diseases are a group of invariably fatal conditions that affect central nervous system (CNS) and more specifically the brain and spinal cord.
The most commonly known prion diseases in human are Fatal Familial Insomnia, Creutzfeldt - Jakob disease (CJD), Gerstmann-Straussler-Scheinker Syndrome, and Kuru, and most commonly identified animal prion diseases are Transmissible mink encephalopathy, Bovine Spongiform Encephalopathy (BSE), Scrapie, and others.BSE (bovine spongiform encephalopathy) is one of the most common neurological disorder found in cattle that results from a transmissible agent called a prion.
According to the Centers for Disease Control and Prevention, five cases of BSE are found in the U.S. and 20 in Canada in 2017.A number of factors such as rising facilities for patients affected by encephalopathy, increasing awareness among people, increasing government assistance, and improvement in regulatory framework are propelling the growth of the global spongiform encephalopathy market.Despite these drivers, challenges in research and development, and poor healthcare system in low and middle-income countries may hamper the growth of the market.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/5031It is estimated that spongiform encephalopathy market is expected to grow at a healthy CAGR of 6.1% during the forecast period 2017-2023.Regional AnalysisEurope dominates the global spongiform encephalopathy market.
It is expected that high prevalence of bovine spongiform encephalopathy in the European region, the support provided by the government bodies for research & development, and improved reimbursement policies in the healthcare are expected to drive the market in Europe region.The Americas hold the second position in the spongiform encephalopathy market owing to the rising awareness among people and high healthcare expenditure.
According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the U.S was reported to be USD 3.2 trillion and hospital care accounted for a share of 32.3%.The Asia Pacific is the fastest growing spongiform encephalopathy market owing to the developing healthcare technology.SegmentationThe spongiform encephalopathy market is segmented on the basis of type, diagnosis, treatment, and end-user.On the basis of the type, the market is segmented into human and animals.
BSE is further classified into classical BSE and atypical BSE.On the basis of the diagnosis, the market is classified into histopathology and immunohistochemistry, immunochemical detection methods, animal bioassays, cell culture assay systems, protein misfolding cyclic amplification, conformation-dependent immunoassay, capillary electrophoresis, fluorescent correlation spectroscopy, multispectral ultraviolet fluorescence spectroscopy, and Fourier transform infrared spectroscopy.
Market HighlightsBSE (bovine spongiform encephalopathy) is one of the most common neurological disorder found in cattle that results from a transmissible agent called a prion.
According to the Centers for Disease Control and Prevention, five cases of BSE are found in the U.S. and 20 in Canada in 2017.
Transmissible spongiform encephalopathy (TSEs) or prion diseases are a group of invariably fatal conditions that affect central nervous system (CNS) and more specifically the brain and spinal cord.
The most commonly known prion diseases in human are Fatal Familial Insomnia, Creutzfeldt - Jakob disease (CJD), Gerstmann-Straussler-Scheinker Syndrome, and Kuru, and most commonly identified animal prion diseases are Transmissible mink encephalopathy, Bovine Spongiform Encephalopathy (BSE), Scrapie, and others.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/5031A number of factors such as rising facilities for patients affected by encephalopathy, increasing awareness among people, increasing government assistance, and improvement in regulatory framework are propelling the growth of the global spongiform encephalopathy market.Despite these drivers, challenges in research and development, and poor healthcare system in low and middle-income countries may hamper the growth of the market.SegmentationThe spongiform encephalopathy market is segmented on the basis of type, diagnosis, treatment, and end-user.On the basis of the type, the market is segmented into human and animals.
The human segment is classified as Creutzfeldt-Jakob disease, Variant Creutzfeldt-Jakob disease (vCJD), and others.
BSE is further classified into classical BSE and atypical BSE.On the basis of the diagnosis, the market is classified into histopathology and immunohistochemistry, immunochemical detection methods, animal bioassays, cell culture assay systems, protein misfolding cyclic amplification, conformation-dependent immunoassay, capillary electrophoresis, fluorescent correlation spectroscopy, multispectral ultraviolet fluorescence spectroscopy, and Fourier transform infrared spectroscopy.
